Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
SWK Holdings Corporation | SWKHL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
25.22 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 24.475 - 25.88 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 25.22 | USD |
SWK Holdings Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
315.33M | 12.50M | - | 44.06M | 15.89M | 1.27 | 19.85 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
SWK News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SWKHL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 25.155 | 25.43 | 25.13 | 25.25 | 2,137 | 0.065 | 0.26% |
1 Month | 25.07 | 25.43 | 24.98 | 25.08 | 3,278 | 0.15 | 0.60% |
3 Months | 25.3899 | 25.88 | 24.81 | 25.08 | 3,541 | -0.1699 | -0.67% |
6 Months | 25.00 | 25.88 | 24.745 | 25.05 | 4,311 | 0.22 | 0.88% |
1 Year | 24.60 | 25.88 | 24.475 | 24.97 | 4,829 | 0.62 | 2.52% |
3 Years | 24.60 | 25.88 | 24.475 | 24.97 | 4,829 | 0.62 | 2.52% |
5 Years | 24.60 | 25.88 | 24.475 | 24.97 | 4,829 | 0.62 | 2.52% |
SWK Description
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment. |